A University of Maryland School of Medicine researcher found a way for patients to take an artificial lung with them when they leave the hospital. In addition to taking pride in the research developed at the Baltimore-based campus, the university also sees business potential.
The “out-of-hospital” artificial lung, developed by Dr. Bartley Griffith, is at the heart of a University of Maryland BioPark-based startup called Breethe, Inc.
This week, University of Maryland’s commercialization arm announced a deal to license the technology to Breethe. UM Ventures is also investing $100,000, marking the second such financial backing the university has made to a company that started with university research. The investment was part of a seed round that the company closed in January.
Griffith is already a distinguished surgeon in heart and transplant surgery. With the new technology, he became a startup founder.
The device is thought to be the first wearable artificial lung that can be taken out of the hospital. In a statement, Griffith said there is a growing demand in the healthcare industry for technology that allows patients to be mobile.
“This is a device that could potentially take patients that are right now hospital-bound and ventilated, and let them leave the hospital and let them resume a fairly normal function,” said UM Ventures Chief Commercialization Officer Phil Robilotto.
Join our growing Slack community
Join 5,000 tech professionals and entrepreneurs in our community Slack today!
Donate to the Journalism Fund
Your support powers our independent journalism. Unlike most business-media outlets, we don’t have a paywall. Instead, we count on your personal and organizational contributions.

Baltimore schools cyberattack compromises staff and student data

Inside the GBC/UpSurge merger: A new economic model is forming, and Baltimore is again a pioneer

Baltimore leaders in tech and entrepreneurship set to speak at Technical.ly’s Builders Conference
